Cargando…
Bioanalysis in the Age of New Drug Modalities
In the absence of regulatory guidelines for the bioanalysis of new drug modalities, many of which contain multiple functional domains, bioanalytical strategies have been carefully designed to characterize the intact drug and each functional domain in terms of quantity, functionality, biotransformati...
Autores principales: | Shi, Jing, Chen, Xuesong, Diao, Jianbo, Jiang, Liying, Li, Lan, Li, Stephen, Liang, Wenzhong, Jin, Xiaoying, Wang, Yonghui, Wong, Colton, Zhang, Xiaolong Tom, Tse, Francis L.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093172/ https://www.ncbi.nlm.nih.gov/pubmed/33942188 http://dx.doi.org/10.1208/s12248-021-00594-w |
Ejemplares similares
-
Pharmacometrics meets statistics—A synergy for modern drug development
por: Ryeznik, Yevgen, et al.
Publicado: (2021) -
Streamlining physiologically‐based pharmacokinetic model design for intravenous delivery of nanoparticle drugs
por: Le, Anh‐Dung, et al.
Publicado: (2022) -
Intracerebroventricular drug administration
por: Atkinson, Arthur J.
Publicado: (2017) -
Quantitative Prediction of Drug–Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?
por: Templeton, IE, et al.
Publicado: (2016) -
Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery
por: Coussens, Nathan P., et al.
Publicado: (2018)